What is ONCY's current stock price?

ONCY (Oncolytics Biotech Inc.) is currently trading at $0.82 with a market cap of $82.5M.

What sector is Oncolytics Biotech Inc. in?

Oncolytics Biotech Inc. (ONCY) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

ONCY Oncolytics Biotech Inc.

Healthcare

$0.82+0.00%OpenMarket Cap: $82.5M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-24.46

P/S

0.00

EV/EBITDA

-3.39

DCF Value

$0.02

FCF Yield

-25.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

5132.0%

ROA

-428.4%

ROIC

-1067.7%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-12.9M	$—
Q4 null	$0.00	$-1.5M	$—
FY null	$0.00	$-39.5M	$—
Q3 null	$0.00	$-14.4M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

3 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2025-11-17

Trading Activity

Insider Trades

View All

Parsons James T.director

BuyFri Mar 13

Kelly Jareddirector, officer: Chief Executive Officer

BuyFri Mar 13

Seizinger Bernd R.director

BuyFri Feb 13

Pisano Waynedirector

BuyFri Feb 13

Look Kirkofficer: Chief Financial Officer

BuyFri Feb 13

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

1.03

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Peers

TIL